The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read more.
FDA approves first drug for myelofibrosis
Most Recent Content
For Nurse Practitioners
Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could
Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...
